drugset / Trial / NCT03158480
Safety and Efficacy of Immune Therapy for Condyloma
RandomizedParallel-groupTriple-blindTreatment
Summary
Cytokine-induced killer (CIK) cells will be co-cultured with HPV induced dendritic cells (DCs); HPV specific DC-CIK will be induced to Condylomata Acuminata patients using interferon, whose recurrence rate and total cost will be compared to Condylomata Acuminata patients only use interferon.
Timeline
- Start
- 2017-06-25
- Primary completion
- 2018-12-31
- Completion
- 2019-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DC-CIK | Cell therapy | — | — |